Cargando…

Role of 25-hydroxyvitamin D in irritable bowel syndrome patients

We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up....

Descripción completa

Detalles Bibliográficos
Autores principales: Alvi, Haris, Ali, Gohar, Iqbal, Sadia, Ahsan, Muhammad Nadeem, Avinash, Siddiqui, Muhammad Ali, Kirmani, Tooba Ahmed, Irshad, Ghazala, Baktashi, Haisum, Asghar, Muhammad Sohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041043/
https://www.ncbi.nlm.nih.gov/pubmed/36994062
http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22
_version_ 1784912620640272384
author Alvi, Haris
Ali, Gohar
Iqbal, Sadia
Ahsan, Muhammad Nadeem
Avinash,
Siddiqui, Muhammad Ali
Kirmani, Tooba Ahmed
Irshad, Ghazala
Baktashi, Haisum
Asghar, Muhammad Sohaib
author_facet Alvi, Haris
Ali, Gohar
Iqbal, Sadia
Ahsan, Muhammad Nadeem
Avinash,
Siddiqui, Muhammad Ali
Kirmani, Tooba Ahmed
Irshad, Ghazala
Baktashi, Haisum
Asghar, Muhammad Sohaib
author_sort Alvi, Haris
collection PubMed
description We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up.
format Online
Article
Text
id pubmed-10041043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-100410432023-03-28 Role of 25-hydroxyvitamin D in irritable bowel syndrome patients Alvi, Haris Ali, Gohar Iqbal, Sadia Ahsan, Muhammad Nadeem Avinash, Siddiqui, Muhammad Ali Kirmani, Tooba Ahmed Irshad, Ghazala Baktashi, Haisum Asghar, Muhammad Sohaib J Family Med Prim Care Case Series We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up. Wolters Kluwer - Medknow 2022-12 2023-01-17 /pmc/articles/PMC10041043/ /pubmed/36994062 http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22 Text en Copyright: © 2023 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Series
Alvi, Haris
Ali, Gohar
Iqbal, Sadia
Ahsan, Muhammad Nadeem
Avinash,
Siddiqui, Muhammad Ali
Kirmani, Tooba Ahmed
Irshad, Ghazala
Baktashi, Haisum
Asghar, Muhammad Sohaib
Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title_full Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title_fullStr Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title_full_unstemmed Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title_short Role of 25-hydroxyvitamin D in irritable bowel syndrome patients
title_sort role of 25-hydroxyvitamin d in irritable bowel syndrome patients
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041043/
https://www.ncbi.nlm.nih.gov/pubmed/36994062
http://dx.doi.org/10.4103/jfmpc.jfmpc_1336_22
work_keys_str_mv AT alviharis roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT aligohar roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT iqbalsadia roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT ahsanmuhammadnadeem roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT avinash roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT siddiquimuhammadali roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT kirmanitoobaahmed roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT irshadghazala roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT baktashihaisum roleof25hydroxyvitamindinirritablebowelsyndromepatients
AT asgharmuhammadsohaib roleof25hydroxyvitamindinirritablebowelsyndromepatients